Inhibitory Effects of a Novel PPAR-γ Agonist MEKT1 on Pomc Expression/ACTH Secretion in AtT20 Cells

Although therapeutic effects of the peroxisome proliferator-activated receptor gamma (PPAR-γ) agonists rosiglitazone and pioglitazone against Cushing's disease have been reported, their effects are still controversial and inconsistent. We therefore examined the effects of a novel PPAR-γ agonist...

Descripción completa

Detalles Bibliográficos
Autores principales: Parvin, Rehana, Noro, Erika, Saito-Hakoda, Akiko, Shimada, Hiroki, Suzuki, Susumu, Shimizu, Kyoko, Miyachi, Hiroyuki, Yokoyama, Atsushi, Sugawara, Akira
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5937427/
https://www.ncbi.nlm.nih.gov/pubmed/29849538
http://dx.doi.org/10.1155/2018/5346272

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5937427/
https://www.ncbi.nlm.nih.gov/pubmed/29849538
http://dx.doi.org/10.1155/2018/5346272

Ejemplares similares